MedTex Ventures
VC Fund
Norwalk, United States
MedTex Ventures is a venture capital firm.
- Total investments:
- 7
- Last investment:
- Lead investor:
- 43%
Last updated:
For AI agents: llms.txt
Industries MedTex Ventures invests in
Stages MedTex Ventures invests in
Countries MedTex Ventures invests in
Investment Focus
Industry
- Medical Device 3 (43%)
- Medical 2 (29%)
- Health Care 2 (29%)
- Biotechnology 2 (29%)
- Analytics 1 (14%)
Stage
- Series A 3 (43%)
- Series B 1 (14%)
- Series C 1 (14%)
Country
- United States 3 (43%)
- United Kingdom 1 (14%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Axis Spine Technologies
|
Axis Spine Technologies is building an expert team to develop highly differentiated products that provide meaningful improvements in patient care. | $12.5M / Series A / Oct 18, 2022 | |
Levita Magnetics
|
As a medical device start up, Levita Magnetics is passionate about developing innovative magnetic surgical platforms that serve as a catalyst in the continued evolution of less invasive surgery.The company's mission is to enhance patient outcomes by minimizing the footprint of surgical procedures across multiple indications and broadpatient populations. It's innovative magnetic surgical platform, called Magnetic Surgery®, is the next step in the evolution of less invasive surgery. | $26M / Series C / Aug 11, 2022 | |
Elucid
|
Based in the Boston biotech and medtech hub, Elucid is focused on improving the accuracy, experience, & cost-effectiveness of cardiovascular diagnostic imaging by leveraging machine learning. Elucid's main product, ElucidVivo, is the first-ever, FDA-cleared, histologically-validated software for evaluating plaque vulnerability from asingle CTA to inform risk of event (heart attack or stroke) & treatment selection. Additionally, Elucid works with pharmaceutical companies, providers, and research organizations to provide quantitative image analysis services. | $27M / Series B / Jun 22, 2022 | |
|
Elucid
|
Based in the Boston biotech and medtech hub, Elucid is focused on improving the accuracy, experience, & cost-effectiveness of cardiovascular diagnostic imaging by leveraging machine learning. Elucid's main product, ElucidVivo, is the first-ever, FDA-cleared, histologically-validated software for evaluating plaque vulnerability from asingle CTA to inform risk of event (heart attack or stroke) & treatment selection. Additionally, Elucid works with pharmaceutical companies, providers, and research organizations to provide quantitative image analysis services. | $27M / Series B / Jun 22, 2022 | |
|
Ictero Medical
|
Ictero Medical is a medical devices company that specializes in helps definitive treatment option for patients. | $6M / Series A / Apr 29, 2022 | |
|
Ictero Medical
|
Ictero Medical is a medical devices company that specializes in helps definitive treatment option for patients. | $6M / Series A / Dec 12, 2021 | |
|
Elucid
|
Based in the Boston biotech and medtech hub, Elucid is focused on improving the accuracy, experience, & cost-effectiveness of cardiovascular diagnostic imaging by leveraging machine learning. Elucid's main product, ElucidVivo, is the first-ever, FDA-cleared, histologically-validated software for evaluating plaque vulnerability from asingle CTA to inform risk of event (heart attack or stroke) & treatment selection. Additionally, Elucid works with pharmaceutical companies, providers, and research organizations to provide quantitative image analysis services. | $10M / Series A / May 10, 2021 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does MedTex Ventures invest in?
MedTex Ventures invests primarily in Medical Device, Medical and Health Care startups, most often at Series A and Series B stage. Most of the 7 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did MedTex Ventures last invest?
The most recent investment recorded for MedTex Ventures closed in Oct 2022. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
